Press Releases

SEATTLE and VANCOUVER, British Columbia, March 13, 2020 /PRNewswire/ -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, today announced fourth quarter and year-end 2019 financia

ROCKLAND, Mass. and NEW YORK, March 13, 2020 /PRNewswire/ -- EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany in the US and Canada, and Pfizer Inc. (NYSE: PFE) today announced an update from the Phase III JAVELIN Head and Neck 100 stud

PALO ALTO, Calif., March 13, 2020 /PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), focused on the development and commercialization of targeted therapies for serious rare and ultra-rare diseases, today reported financial results for the fourth quarter and full year 2019 and provided a business update. 

ESCHBORN, Germany, March 13, 2020 /PRNewswire/ -- The Supervisory Board of Innoplexus AG has appointed Christian Bigatà Joseph (45) as CFO, effective as of February 1, 2020. Christian has more than 20 years of Finance expertise, the largest part spent in management positions in Tech and Data companies. He has served as CFO and Member

SALT LAKE CITY, March 13, 2020 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a clinical-stage biopharmaceutical company, today announced financial results for the year ended December 31, 2019, and provided a corporate update.

TAMPA, Fla., March 13, 2020 /PRNewswire/ -- Bisk Education, Inc. (Bisk), a global leader in digital learning, announced it will be extending its

DURHAM, N.C., March 13, 2020 /PRNewswire/ -- TARGET PharmaSolutions Inc., a real-world evidence clinical data company, announced today the launch of its seventh observational cohort study, TARGET-ASTHMA."TARGET-ASTHMA will capture important data on patients with asthma in the real world," said Steering Committee Chair, Michael Wechsler

LOS ANGELES, March 13, 2020 /PRNewswire/ -- Science 37, the industry leader in decentralized clinical trials, today published a report examining key considerations for patient safety and business continuity in the clinical trial industry in light of the current COVID-19 pandemic.

NEW HAVEN, Conn., March 13, 2020 /PRNewswire/ -- Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) today announced a Patient Savings Program for NURTEC™ ODT (rimegepant) that is now available for eligible commercially insured patients. The co-pay savings card can be obtained at the

Thousands of canine and feline specimens tested surfaced no positive results to date  WESTBROOK, Maine, March 13, 2020 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics and software, today announced that the company has seen no positive results in pets to date of SARS-CoV-2, the coronavirus strain